A Phase I Trial of Anti-LAG-3 or Anti-CD137 Alone and in Combination with Anti-PD-1 in Patients with Recurrent GBM

Grant

Date/time Interval

  • June 30, 2016 - June 2, 2021

    • Awarded By

    Total Award Amount

  • 12000.00

    • Direct Costs

  • 6180.00

    • Sponsor Award Id

    • Contributor

  • Hassan Fathallah-Shaykh M.D., Ph.D.   Investigator  
  • Louis Nabors M.D.   Principal Investigator  
  • Xiaosi Han   Investigator